A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma (LEBEN)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Antonio Pinto, Fondazione Giovanni Pascale
ClinicalTrials.gov Identifier:
NCT01412307
First received: August 3, 2011
Last updated: August 8, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2016
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
Publications:
http://meetinglibrary.asco.org/content/132091-144